此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

增加家庭气管造口护理资源 (BREATHE)

2026年9月25日 更新者:Karen Sepucha、Massachusetts General Hospital

增加家庭气管切开护理的资源和护理人员的能力:一项务实的随机试验

The goal of this trial is to advance the understanding of how to best support caregivers of children with tracheostomies who are caring for their child at home. The main questions it aims to answer are:

  • What are the best ways to support caregivers post-discharge with both medical and nonmedical decisions about resuming life, work, and family activities, while safely caring for their child with a tracheostomy at home?
  • How can the investigators leverage existing technology to facilitate communication between inpatient and outpatient care teams to better support needs of pediatric patients and caregivers post-discharge?

Caregiver participants will be randomly assigned to receive Trach Me Home (gold standard discharge program) or Trach Me Home with additional components. Caregiver participants will complete three surveys over the course of 6 months. Researchers will see if caregivers in the Trach Me Home with additional components report lower caregiver burden at 4 weeks post discharge (primary outcome) and fewer hospital readmissions at 6 months than those in Trach Me Home arm.

研究概览

详细说明

The study is focused on a rare and medically complex population of children with tracheostomies. The study is a Type I hybrid effectiveness-implementation study using a pragmatic randomized trial at six participating sites. The goal of this trial is to advance the understanding of how to best support caregivers of children with tracheostomies who are caring for their child at home. The main question[s] it aims to answer are:

  • What are the best ways to support caregivers post-discharge with both medical and nonmedical decisions about resuming life, work, and family activities, while safely caring for their child with a tracheostomy at home?
  • How can the investigators leverage existing technology to facilitate communication between inpatient and outpatient care teams to better support needs of pediatric patients and caregivers post-discharge?

Caregiver participants will randomly assigned to the Comparator arm (gold standard discharge program) or to the Intervention arm (gold standard program with other components). Caregiver participants will complete three surveys over the course of 6 months. The investigators will test two main hypotheses: the Intervention arm will have (1) significantly lower caregiver burden at 4 weeks post discharge (primary outcome) and (2) significantly lower readmissions or emergency room visits at 6 months post discharge than the Comparator arm.

The investigators will also survey pediatricians of participating patients at 6 months post discharge and examine whether intervention arm pediatricians have higher satisfaction with discharge communication than those in comparator arm.

研究类型

介入性

注册 (估计的)

480

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • California
      • La Jolla、California、美国、92093
        • University of San Diego Rady Children's Hospital
    • Maryland
      • Silver Spring、Maryland、美国、20910
        • Children's National Medical Center, Children's Research Institute
    • Massachusetts
      • Boston、Massachusetts、美国、02114
        • Massachusetts General Hospital
    • Minnesota
      • Minneapolis、Minnesota、美国、55404
        • Children's Hospitals and Clinics of Minnesota
    • Ohio
      • Cincinnati、Ohio、美国、45229
        • Cincinnati Children's Hospital Medical Center
    • Pennsylvania
      • Philadelphia、Pennsylvania、美国、19146
        • Children's Hospital of Philadelphia

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Lead or primary adult caregiver (18 or older) of infants or children (0-17 years old) with tracheostomy who are planning for discharge to home, including children who are dependent on ventilator

Exclusion Criteria:

  • Patients transferred to other hospital or facility (and/or not discharged to home during study period)
  • Primary caregiver unable to read or write in English, Spanish, Mandarin, or Arabic
  • Not residing in the U.S. for at least 12 months after discharge

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:卫生服务研究
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
有源比较器:Active Comparator Caregivers

TrachMeHome program delivered in the hospital including education, skills training and case management for caregivers

The Trach Me Home discharge program includes caregiver education, skills training and case management.

实验性的:Intervention Caregivers

Trach Me Home and Trach Plus with additional education, outpatient care team communication and social support for caregivers.

The Trach Me Home discharge program includes caregiver education, skills training and case management.

The Trach Plus program includes education, social support, and outreach to outpatient care team.

有源比较器:Active Comparator Physicians

Primary care physicians' of the enrolled participant's child receiving discharge communication

The Trach Me Home discharge program includes caregiver education, skills training and case management.

实验性的:Intervention Physicians

Primary care physicians' of the enrolled participant's child receiving outpatient care team communication prior to discharge

The Trach Me Home discharge program includes caregiver education, skills training and case management.

The Trach Plus program includes education, social support, and outreach to outpatient care team.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Caregiver Burden
大体时间:4 weeks post-discharge

Pediatric Tracheostomy Health Status Instrument (PTHSI) Caregiver burden subscale, total scores range from 0-68. Higher scores indicate higher burden.

4 weeks post-discharge

次要结果测量

结果测量
措施说明
大体时间
Medical Complications Associated with Tracheostomy
大体时间:6 months post-discharge

4-item modified Medical Complications Associated with Tracheostomy (MCAT) measure that includes 4 caregiver reported items to assess the total number of urgent medical visits, emergency room and readmissions for tracheostomy-related issues. Items are summed and scores start at 0 and there is no upper limit. Higher total numbers are worse.

6 months post-discharge
6-month Readmission Rate
大体时间:6 months post-discharge

Percentage with one or more emergency room visits or hospital readmissions as documented in the electronic health record within 6 months of discharge.

6 months post-discharge
Frequency of pediatrician communication
大体时间:6 months post-discharge

Percentage of pediatrician-specific communication with inpatient team prior to and/or shortly after discharge documented in electronic medical record or by pediatrician report.

6 months post-discharge
Primary care pediatrician satisfaction
大体时间:6 months post-discharge

Clinician reported satisfaction with discharge communication scored from 0-100, higher scores indicate higher satisfaction with discharge communication.

6 months post-discharge
Medical Complications Associated with Tracheostomy
大体时间:4 weeks post-discharge

4-item modified Medical Complications Associated with Tracheostomy (MCAT) measure that includes 4 caregiver reported items to assess the total number of urgent medical visits, emergency room and readmissions for tracheostomy-related issues. Items are summed and scores start at 0 and there is no upper limit. Higher total numbers are worse.

4 weeks post-discharge
Caregiver Burden
大体时间:6 months post-discharge

Pediatric Tracheostomy Health Status Instrument (PTHSI) Caregiver burden subscale, total scores range from 0-68. Higher scores indicate higher burden.

6 months post-discharge

其他结果措施

结果测量
措施说明
大体时间
Number of readmissions
大体时间:6 months post discharge

The total number of electronic health record documented emergency room visits and hospital admissions will be collected, with higher numbers being worse (indicating more readmissions).

6 months post discharge

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Karen Sepucha, PhD、Massachusetts General Hospital
  • 首席研究员:Christopher Hartnick, MD、Massachusetts Eye and Ear Infirmary / Massachusetts General Hospital

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2024年5月16日

初级完成 (估计的)

2026年12月1日

研究完成 (估计的)

2027年10月1日

研究注册日期

首次提交

2024年2月21日

首先提交符合 QC 标准的

2024年2月21日

首次发布 (实际的)

2024年2月28日

研究记录更新

最后更新发布 (实际的)

2026年9月30日

上次提交的符合 QC 标准的更新

2026年9月25日

最后验证

2026年9月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • 2023P001695
  • IHS-2022C1-26100 (其他赠款/资助编号:Patient Centered Outcomes Research Institute (PCORI))

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

是的

IPD 计划说明

To promote research replicability, transparency and future use of the data, de-identified data sets will be created and will be available, by request, to outside researchers.

The Data Package (comprised of the de-identified Analyzable Data Set, Full Protocol, metadata, data dictionary, full statistical analysis plan, and analytic code from the project) will be deposited in the Patient-Centered Outcomes Research Institute's Data Repository at the ICPSR. Participant information sheets for the study will indicate that de-identified information will be deposited in an open access service to promote use of the data by other researchers. No information that contains identifiers or that could be used to link an individual to the data will be included in the de-identified data set. No data will be provided from qualitative transcripts as this may lead to identifying information about participants. However, codes abstracted from qualitative transcripts may be made available.

IPD 共享时间框架

After study results have been published, about 1 year after the end of the funded grant period, the study materials and de-identified data will be placed on an open access service such as ICPSR where they will be available indefinitely.

IPD 共享访问标准

Researchers may access the data through the PCORI-designated repository (ICPSR's website) once it is made available.

IPD 共享支持信息类型

  • 研究方案
  • 树液
  • 分析代码

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅